Thence, it is extremely significant to unearth novel diagnostic biomarkers for PDAC, which can indicate the use of curative surgical treatment ( 6 ).
← all excerpts
Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinoma.
1
—
—